H Spectrum, a Taiwan-based healthcare foundation founded by Foxconn Group chairman Terry Guo, have entered into a memorandum of understanding (MOU) with the German life sciences group Merck KGaA to establish H Spectrum & Merck Innovation Lab. H Spectrum is a start-up platform hosted by Gou's YongLin Healthcare Foundation.

Through the lab, Merck and Foxconn will focus on collaborations in four areas, including precision medicine, liquid biopsy, bio-sensors and interface, as well as patient management.

The two companies will also support Taiwan's biotech start-ups in the four areas.

Since Merck has already been supplying special materials to the Foxconn Group for a long time, the new partnership is expected to further advance Foxconn's involvement in biotechnology business, some market watchers pointed out.

source by : Source 1 , Source 2 
  • ASIA

    15F, 207-5, Beixin Rd., Sec. 3, New Taipei City, 23143 Taiwan

  • HQ

    611 E Wisconsin Ave
    Milwaukee, WI 53202


    E: info@dcihealthtech.com